Ausdal Financial Partners, Inc. Trevena Inc Transaction History

Ausdal Financial Partners, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 01, 2021	SELL	$2.13 - $3.26 $42,600 - $65,199	-20,000 Reduced 66.67%	10,000 $21,000
Q3 2020 Nov 04, 2020	SELL	$1.53 - $3.13 $15,300 - $31,300	-10,000 Reduced 25.0%	30,000 $90,000
Q1 2020 May 04, 2020	SELL	$0.56 - $0.97 $1,120 - $1,940	-2,000 Reduced 4.76%	40,000 $26,000
Q4 2019 Feb 14, 2020	SELL	$0.62 - $1.06 $620 - $1,060	-1,000 Reduced 2.33%	42,000 $39,000
Q4 2018 Feb 11, 2019	BUY	$0.39 - $3.47 $16,770 - $149,210	43,000 New	43,000 $18,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $34.7M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Ausdal Financial Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ausdal Financial Partners, Inc. with notifications on news.